BIFIDO Co. Ltd (238200) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.001x

Based on the latest financial reports, BIFIDO Co. Ltd (238200) has a cash flow conversion efficiency ratio of -0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-31.26 Million ≈ $-21.19K USD) by net assets (₩44.44 Billion ≈ $30.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 238200 market cap for the company's overall valuation and market capitalisation.

BIFIDO Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how BIFIDO Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BIFIDO Co. Ltd stock quote for real-time trading data and today's change.

BIFIDO Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BIFIDO Co. Ltd ranked by their cash flow conversion efficiency. Review 238200 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Yulho Co. Ltd
KQ:072770
-0.042x
Prajay Engineers Syndicate Limited
NSE:PRAENG
0.053x
CTRL Group Limited Ordinary Shares
NASDAQ:MCTR
-0.546x
SPECO Ltd
KQ:013810
0.011x
Batavia Prosperindo Trans Tbk PT
JK:BPTR
0.153x
COCRYSTAL PHARMA NEW O.N.
F:8CC
-0.274x
COSMOS HEALTH NEW DL-01
F:V67A
-0.249x
Capital Point
TA:CPTP
-0.017x

Annual Cash Flow Conversion Efficiency for BIFIDO Co. Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of BIFIDO Co. Ltd from 2016 to 2025. Also see BIFIDO Co. Ltd balance sheet assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩45.93 Billion
≈ $31.13 Million
₩3.95 Billion
≈ $2.68 Million
0.086x +660.57%
2024-12-31 ₩46.69 Billion
≈ $31.64 Million
₩-716.29 Million
≈ $-485.42K
-0.015x -127.85%
2023-12-31 ₩51.70 Billion
≈ $35.04 Million
₩2.85 Billion
≈ $1.93 Million
0.055x +54.19%
2022-12-31 ₩52.49 Billion
≈ $35.57 Million
₩1.88 Billion
≈ $1.27 Million
0.036x -11.12%
2021-12-31 ₩50.64 Billion
≈ $34.32 Million
₩2.04 Billion
≈ $1.38 Million
0.040x -3.97%
2020-12-31 ₩44.60 Billion
≈ $30.22 Million
₩1.87 Billion
≈ $1.27 Million
0.042x -26.86%
2019-12-31 ₩46.29 Billion
≈ $31.37 Million
₩2.65 Billion
≈ $1.80 Million
0.057x -46.13%
2018-12-31 ₩44.73 Billion
≈ $30.31 Million
₩4.75 Billion
≈ $3.22 Million
0.106x -49.13%
2017-12-31 ₩18.50 Billion
≈ $12.53 Million
₩3.86 Billion
≈ $2.62 Million
0.209x +0.49%
2016-12-31 ₩16.07 Billion
≈ $10.89 Million
₩3.34 Billion
≈ $2.26 Million
0.208x --

About BIFIDO Co. Ltd

KQ:238200 Korea Packaged Foods
Market Cap
$14.91 Million
₩22.00 Billion KRW
Market Cap Rank
#26064 Global
#1954 in Korea
Share Price
₩2690.00
Change (1 day)
-1.28%
52-Week Range
₩2310.00 - ₩2790.00
All Time High
₩2790.00
About

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.